Respiratory Cancers

miRNA in mesothelioma

miRNA in mesothelioma

Limited treatment options in Mesothelioma lead to a short median survival and clinical management is hampered by the lack of molecular biomarkers for diagnosis/prognosis.

There is growing evidence that short non-coding RNAs such as microRNA (miRNA), are useful biomarkers in cancer. Studies at the Institute for Respiratory Health are trying to determine the diagnostic and prognostic potential of miRNAs in serum and pleural effusion fluids and cells from patients with mesothelioma compared with other diseases.

The Institute’s researchers also worked a project seeking to determine if differentially expressed serum miRNAs are early disease markers. miRNA also have important biological roles within cells so we are also looking at the biological significance of certain miRNAs in mesothelioma.

To get involved or for more information, contact the Research Leader.

miRNA in mesothelioma was last modified: April 7th, 2017 by Sarah Cermak

Research Leaders

Dr Cecilia Prêle

BSc (Hons), PhD

Head of Tissue Repair Group

cecilia.prele@uwa.edu.au
LinkedIn

Dr Cecilia Prêle was last modified: February 24th, 2017 by Sarah Cermak

A/Prof Steve Mutsaers

BSc (Hons), PhD

Research Associate Professor

steve.mutsaers@resphealth.uwa.edu.au
LinkedIn

A/Prof Steve Mutsaers was last modified: April 7th, 2017 by Sarah Cermak

miRNA in mesothelioma was last modified: April 7th, 2017 by Sarah Cermak